z-logo
open-access-imgOpen Access
In Vivo Activity of Aryl Ozonides against Schistosoma Species
Author(s) -
Jennifer Keiser,
Katrin Ingram,
Mireille Vargas,
Jacques Chollet,
Xiaofang Wang,
Yuxiang Dong,
Jonathan L. Vennerstrom
Publication year - 2011
Publication title -
antimicrobial agents and chemotherapy
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.07
H-Index - 259
eISSN - 1070-6283
pISSN - 0066-4804
DOI - 10.1128/aac.05371-11
Subject(s) - schistosoma mansoni , in vivo , schistosoma , biology , pharmacology , schistosomiasis , chemistry , microbiology and biotechnology , toxicology , helminths , immunology
We evaluated the in vivo antischistosomal activities of 11 structurally diverse synthetic peroxides. Of all compounds tested, ozonide (1,2,4-trioxolane) OZ418 had the highest activity against adult Schistosoma mansoni, with total and female worm burden reductions of 80 and 90% (P < 0.05), respectively. Furthermore, treatment of S. haematobium-infected mice with OZ418 reduced the total worm burden by 86%. In conclusion, OZ418 is a promising antischistosomal lead compound.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom